OFIX
Orthofix Medical Inc
9.20$
-2.2%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 43.5% | 45.4% | 44.0% | 43.8% | 44.5% | 48.5% | 47.4% | 47.3% | 47.3% | 49.0% | 52.1% | 51.1% | |
| 3.7% | 3.6% | 3.0% | 3.0% | 3.5% | 9.3% | 7.0% | 7.8% | 7.9% | 9.6% | 13.6% | 11.9% | |
| 3.7% | 3.6% | 3.0% | 3.0% | 3.5% | 9.3% | 7.0% | 7.8% | 7.9% | 9.6% | 13.6% | 11.9% | |
| 12.6% | 13.8% | 13.9% | 14.2% | 14.4% | 15.1% | 16.0% | 15.5% | 15.7% | 16.0% | 15.5% | 15.6% | |
| 24.5% | 24.0% | 24.2% | 23.8% | 23.7% | 21.2% | 21.2% | 20.7% | 20.9% | 20.3% | 20.1% | 21.1% | |
| 21.5% | 21.1% | 21.5% | 22.1% | 22.5% | 21.8% | 23.7% | 23.3% | 23.4% | 22.9% | 22.0% | 22.3% | |
| 13.4% | 12.7% | 12.4% | 12.3% | 12.0% | 11.1% | 9.9% | 9.4% | 9.1% | 8.6% | 7.8% | 7.6% | |
| 32.0% | 35.3% | 37.1% | 38.1% | 39.4% | 43.7% | 44.3% | 45.2% | 46.9% | 47.1% | 50.9% | 50.8% | |
| 16.8% | 17.9% | 16.6% | 17.7% | 18.7% | 18.9% | 17.5% | 17.7% | 19.2% | 20.0% | 18.2% | 18.0% | |
| 0.1% | 0.6% | 0.4% | 0.6% | 0.8% | 0.5% | 0.6% | 0.5% | 0.5% | 0.5% | 0.0% | 0.0% | |
| 5.9% | 6.3% | 6.3% | 5.7% | 5.4% | 5.5% | 5.5% | 5.4% | 6.1% | 6.9% | 6.2% | 7.3% | |
| 7.7% | 10.1% | 12.7% | 12.8% | 12.9% | 17.6% | 19.1% | 18.8% | 18.9% | 18.5% | 25.0% | 25.4% | |
| 68.0% | 64.7% | 62.9% | 61.9% | 60.6% | 56.3% | 55.7% | 54.8% | 53.1% | 52.9% | 49.1% | 49.2% | |
| -14.1% | -16.2% | -20.5% | -24.9% | -28.5% | -30.9% | -40.0% | -41.0% | -44.0% | -43.3% | -43.9% | -46.4% | |
| 4.1% | 4.0% | 4.2% | 4.3% | 4.4% | 4.3% | 4.8% | 4.7% | 4.8% | 4.7% | 4.6% | 4.7% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.